News

generic

One immune variable predicts poor outcomes across tumour types and species

6 February 2026
Tumour containing infiltrating neutrophils - Credit © Mikaël Pittet – UNIGE

Immune 'hijacking' predicts cancer evolution

6 February 2026
brain

5-FU chemotherapy linked to rare brain toxicity in cancer patient

6 February 2026
CRISPR editing

Not all cancer mutations are equal: Mutation strength in a single gene shapes tumour behaviour

5 February 2026
Cancer Genome Atlas Network maps colorectal cancer - 3237.png

Researchers create reliable atlas of cell types found in breast cancers

5 February 2026
MRI

Half of all men over 60 have prostate cancer – an AI diagnostic tool could identify which need followup

5 February 2026
primary glioblastoma

Scientists ID potential treatment for deadliest brain cancer

5 February 2026
A phase II study of thalidomide and temozolomide in patients with brain metastases from malignant melanoma: lymphopenia correlates with response - resized_Pizzigoni4crop.jpg

Study in US veterans identifies agent orange exposure as a risk factor for rare skin cancer

5 February 2026
antigen-capturing nanoparticles - immunotherapy

Yeast cells can be used for rapid testing of cancer immunotherapy

5 February 2026
Doctor generic

Scientists crack the rules of gene regulation with experimental elegance and AI

5 February 2026
generic researcher lab microscope

Scientists identify optimal design for off-the-shelf immunotherapy targeting solid tumours

5 February 2026
Cancer cells in culture from human connective tissue - NCI Visuals

Unlocking “hidden” modes: A new physics-driven approach to label-free cancer cell phenotyping

5 February 2026
Back to Top